Another study revealed that tRF-3023 directly targets the mRNA of the cell cycle suppressor Cyclin-dependent kinase inhibitor 1A (CDKN1A, p21), accelerating the transition from G1 to S phase and thereby promoting malignant proliferation in hepatocellular carcinoma cells [68]. Here, CDKN1A is linked to hepatocellular carcinoma.